Expanding Endocrine Therapy Options for Patients With Ductal Carcinoma In Situ-More Work to Do.
Publication
, Journal Article
Plichta, JK; Greenup, RA
Published in: JAMA Surg
December 1, 2023
Duke Scholars
Published In
JAMA Surg
DOI
EISSN
2168-6262
Publication Date
December 1, 2023
Volume
158
Issue
12
Start / End Page
1274
Location
United States
Related Subject Headings
- Mastectomy, Segmental
- Mammography
- Humans
- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma, Ductal, Breast
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Plichta, J. K., & Greenup, R. A. (2023). Expanding Endocrine Therapy Options for Patients With Ductal Carcinoma In Situ-More Work to Do. JAMA Surg, 158(12), 1274. https://doi.org/10.1001/jamasurg.2023.5111
Plichta, Jennifer K., and Rachel A. Greenup. “Expanding Endocrine Therapy Options for Patients With Ductal Carcinoma In Situ-More Work to Do.” JAMA Surg 158, no. 12 (December 1, 2023): 1274. https://doi.org/10.1001/jamasurg.2023.5111.
Plichta JK, Greenup RA. Expanding Endocrine Therapy Options for Patients With Ductal Carcinoma In Situ-More Work to Do. JAMA Surg. 2023 Dec 1;158(12):1274.
Plichta, Jennifer K., and Rachel A. Greenup. “Expanding Endocrine Therapy Options for Patients With Ductal Carcinoma In Situ-More Work to Do.” JAMA Surg, vol. 158, no. 12, Dec. 2023, p. 1274. Pubmed, doi:10.1001/jamasurg.2023.5111.
Plichta JK, Greenup RA. Expanding Endocrine Therapy Options for Patients With Ductal Carcinoma In Situ-More Work to Do. JAMA Surg. 2023 Dec 1;158(12):1274.
Published In
JAMA Surg
DOI
EISSN
2168-6262
Publication Date
December 1, 2023
Volume
158
Issue
12
Start / End Page
1274
Location
United States
Related Subject Headings
- Mastectomy, Segmental
- Mammography
- Humans
- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma, Ductal, Breast
- 3202 Clinical sciences